help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toledo, S. P.
Right arrow Articles by Kremer H Themmen, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toledo, S. P.
Right arrow Articles by Kremer H Themmen, A. P.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 3850-3854, Copyright © 1996 by Endocrine Society


ARTICLES

An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female

SP Toledo, HG Brunner, R Kraaij, M Post, PL Dahia, CY Hayashida and AP Kremer H Themmen
Department of Medicine, Sao Paulo University School of Medicine, Brazil.

Hypergonadotropic hypogonadism is characterized by decreased gonadal function due to the inability of the gonads to respond to pituitary gonadotropins. Hypergonadotropic hypogonadism in females has many causes, among which are ovarian dysgenesis and abnormalities of the ovarian receptors for the pituitary gonadotropins. We evaluated a woman who presented with amenorrhea due to hypergonadotropic hypogonadism, but who had structurally normal ovaries. She is a sister of two previously identified 46,XY male pseudohermaphrodites with Leydig cell hypoplasia. Injection of hCG did not cause any change in plasma levels of estradiol or progesterone, suggesting complete ovarian resistance to LH. Analysis of the DNA sequence of the LH receptor gene revealed that the patient is homozygous for the same single base change as her two brothers. This mutation causes substitution of an alanine residue by a proline at position 593. In vitro analysis of the mutant LH receptor in cultured human embryonic kidney 293 cells documented that the receptor is unable to stimulate adenylyl cyclase in response to hCG. Plasma levels of estradiol and progesterone were low, whereas LH and FSH levels were increased. On histological analysis of the ovary, follicles were seen at all developmental stages. Nonetheless, primary amenorrhea had been present for 5 yr, and repeated measurements of plasma estradiol and progesterone indicate that ovulation does not occur. These results document the existence of inherited LH resistance as a cause of primary amenorrhea in women. The combined clinical and molecular observations are consistent with previous experimental data suggesting that in humans, LH is necessary for ovulation but follicular maturation can occur in the presence of FSH alone.


This article has been cited by other articles:


Home page
Hum ReprodHome page
M. Bruysters, S. Christin-Maitre, M. Verhoef-Post, C. Sultan, J. Auger, I. Faugeron, L. Larue, S. Lumbroso, A.P.N. Themmen, and P. Bouchard
A new LH receptor splice mutation responsible for male hypogonadism with subnormal sperm production in the propositus, and infertility with regular cycles in an affected sister
Hum. Reprod., August 1, 2008; 23(8): 1917 - 1923.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. Lofrano-Porto, G. B. Barra, L. A. Giacomini, P. P. Nascimento, A. C. Latronico, L. A. Casulari, and F. d. A. da Rocha Neves
Luteinizing Hormone Beta Mutation and Hypogonadism in Men and Women
N. Engl. J. Med., August 30, 2007; 357(9): 897 - 904.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
T R. Kumar
What have we learned about gonadotropin function from gonadotropin subunit and receptor knockout mice?
Reproduction, September 1, 2005; 130(3): 293 - 302.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Yamashita, K. Nakamura, Y. Omori, K. Tsunekawa, M. Murakami, and T. Minegishi
Association of Human Follitropin (FSH) Receptor with Splicing Variant of Human Lutropin/Choriogonadotropin Receptor Negatively Controls the Expression of Human FSH Receptor
Mol. Endocrinol., August 1, 2005; 19(8): 2099 - 2111.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Z.M. Lei, S. Mishra, P. Ponnuru, X. Li, Z.W. Yang, and Ch.V. Rao
Testicular Phenotype in Luteinizing Hormone Receptor Knockout Animals and the Effect of Testosterone Replacement Therapy
Biol Reprod, November 1, 2004; 71(5): 1605 - 1613.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-X. Tao, N. B. Johnson, and D. L. Segaloff
Constitutive and Agonist-dependent Self-association of the Cell Surface Human Lutropin Receptor
J. Biol. Chem., February 13, 2004; 279(7): 5904 - 5914.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. L. Powell, D. Piersma, M. E. Kevenaar, I. L. van Staveren, A. P. N. Themmen, B. J. Iacopetta, and E. M. J. J. Berns
Luteinizing Hormone Signaling and Breast Cancer: Polymorphisms and Age of Onset
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1653 - 1657.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. H. Burns and M. M. Matzuk
Minireview: Genetic Models for the Study of Gonadotropin Actions
Endocrinology, August 1, 2002; 143(8): 2823 - 2835.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. N. Kalantaridou and G. P. Chrousos
Monogenic Disorders of Puberty
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2481 - 2494.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Ascoli, F. Fanelli, and D. L. Segaloff
The Lutropin/Choriogonadotropin Receptor, A 2002 Perspective
Endocr. Rev., April 1, 2002; 23(2): 141 - 174.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
L C Layman
Human gene mutations causing infertility
J. Med. Genet., March 1, 2002; 39(3): 153 - 161.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Z. M. Lei, S. Mishra, W. Zou, B. Xu, M. Foltz, X. Li, and Ch. V. Rao
Targeted Disruption of Luteinizing Hormone/Human Chorionic Gonadotropin Receptor Gene
Mol. Endocrinol., January 1, 2001; 15(1): 184 - 200.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
D. P. Levy, J. M. Navarro, G. L. Schattman, O. K. Davis, and Z. Rosenwaks
The role of LH in ovarian stimulation: Exogenous LH: let's design the future
Hum. Reprod., November 1, 2000; 15(11): 2258 - 2265.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. P. N. Themmen and I. T. Huhtaniemi
Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal Function
Endocr. Rev., October 1, 2000; 21(5): 551 - 583.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. C. Zenteno, P. Canto, S. Kofman-Alfaro, and J. P. Mendez
Evidence for Genetic Heterogeneity in Male Pseudohermaphroditism due to Leydig Cell Hypoplasia
J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3803 - 3806.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S.-M. Wu, K. M. Hallermeier, L. Laue, C. Brain, A. C. Berry, D. B. Grant, J. E. Griffin, J. D. Wilson, G. B. Cutler Jr., and W.-Y. Chan
Inactivation of the Luteinizing Hormone/Chorionic Gonadotropin Receptor by an Insertional Mutation in Leydig Cell Hypoplasia
Mol. Endocrinol., November 1, 1998; 12(11): 1651 - 1660.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
S. S. Stavrou, Y.-S. Zhu, L.-Q. Cai, M. D. Katz, C. Herrera, M. DeFillo-Ricart, and J. Imperato-McGinley
A Novel Mutation of the Human Luteinizing Hormone Receptor in 46XY and 46XX Sisters
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2091 - 2098.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
B. C. J. M. Fauser and A. M. van Heusden
Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences
Endocr. Rev., February 1, 1997; 18(1): 71 - 106.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society